表紙
市場調查報告書
商品編碼
967205

亞太地區手術部位感染管理市場預測(2021-2028)

Asia Pacific Surgical Site Infection Control Market Forecast 2021-2028

出版日期: | 出版商: Inkwood Research | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在2021年至2028年的預測期內,亞太地區外科手術部位感染控制的市場規模預計將以6.39%的複合年增長率增長。該地區市場的主要增長因素包括人口眾多,醫療感染的流行以及療養院的激增。

在日本,日本環境感染學會於1999年建立了醫院內感染控制監測,並引入了手術部位感染(SSI)監測。厚生勞動省於2002年7月啟動了國家SSI監視計劃,SSI調查研究組於2002年10月成立。在日本,手術部位感染的總發病率較高,並且已經採取措施來改善發病率,這是市場的增長因素之一。

本報告調查了亞太地區的手術部位感染管理市場,以及市場規模/估計,機遇與挑戰,增長與抑制因素,策略,手術/感染類型/最終用戶/國家市場。它提供信息,例如分析,競爭情況和主要公司的概況。

目錄

第1章調查範圍和調查方法

  • 調查目的
  • 調查範圍
  • 調查方法
  • 先決條件和限制

第2章執行摘要

  • 市場規模/估計
  • 市場概況

第3章市場動態

  • 主要增長因素
    • 手術率提高
    • 老年人口迅速增加
    • 實施預防院內感染的監管指南
    • 醫院內感染髮生率增加
  • 主要抑制因素
    • 對醫院內感染缺乏認識
    • 由於使用了一次性醫療用品,醫療廢物迅速增加

第4章主要分析

  • 波特的五力分析
  • COVID-19的影響
  • 機會矩陣
  • 供應商狀況
  • 重要投資見解

第5章市場分析:按手術

  • 腹腔鏡檢查
  • 骨科手術
  • 心血管
  • 婦產科
  • 傷口閉合
  • 美容和整形外科
  • 胸外科
  • 微血管
  • 泌尿科
  • 神經外科
  • 其他

第6章市場分析:按感染類型

  • 皮膚表面切口
  • 深切口
  • 器官/體腔

第7章市場分析:按最終用戶

  • 醫院
  • 門診手術中心

第8章市場分析:按產品

  • 消毒劑
  • 手動洗消機解決方案
  • 手術單
  • 手術手套
  • 皮膚準備溶液
  • 外科沖洗
  • 外科磨砂膏
  • Varican
  • 醫用無紡布
  • 其他產品

第9章市場分析:按地區

  • 亞太地區
    • 市場規模/估計
    • 主要增長動力
    • 主要問題
    • 主要公司
    • 國家分析

第10章競爭情況

  • 主要戰略發展
    • 併購
    • 產品發佈和開發
    • 聯盟,合同/合同與合作
    • 業務擴展/批准/公告
  • 公司簡介
    • 3M COMPANY
    • AMERICAN POLYFILM
    • ANSELL LTD
    • BECTON, DICKINSON AND COMPANY (BD)
    • BELIMED AG
    • BIOMERIEUX SA
    • GAMA HEALTHCARE
    • GETINGE AB
    • JOHNSON & JOHNSON
    • KIMBERLY-CLARK
    • LAC-MAC
    • PACON MANUFACTURING CORPORATION
    • SOTERA HEALTH LLC
    • STERIS CORPORATION
    • STRYKER CORPORATION
目錄
Product Code: 34491

KEY FINDINGS

The Asia Pacific surgical site infection control market is evaluated to project a CAGR of 6.39%, during the forecast period of 2021 to 2028. The region's key market growth propellers include the large population base, the growing prevalence of healthcare-associated infections, and the surging geriatric populace.

MARKET INSIGHTS

The Asia Pacific surgical site infection control market growth is analyzed by assessing Japan, Australia & New Zealand, Indonesia, Thailand, China, Vietnam, South Korea, India, and the rest of the Asia Pacific. Surgical site infections are characterized by major postoperative complications, leading to an infection. They require prolonged hospital stays, higher expenses, as well as patients' dissatisfaction, in terms of surgical treatment. As a result, the surveillance of such infections is crucial for investigating their cause and prevalence, while being an effective control activity, to reduce the rates of infection.

For instance, in 1999, the Japanese Nosocomial Infection Surveillance System, was established by the Japanese Society of Environmental Infections, thereby introducing the surgical site infection (SSI) surveillance, in Japan. Moreover, in July, 2002, the Japanese Ministry of Health and Welfare began a national SSI surveillance program, whereas, the SSI surveillance study group was established in October, 2002. This was primarily initiated to reinforce the Ministry's investigation, and to introduce activities that further augment, and enhance the quality of Japan's SSI surveillance. Besides, the total incidence of surgical site infections in Japan is relatively high, and therefore, measures are being taken to improve their incidence. Hence, these factors are attributed to the surgical site infection control market growth.

COMPETITIVE INSIGHTS

Some of the prominent companies operating in the market are, Ansell Ltd, Johnson & Johnson, Becton, Dickinson and Company (BD), 3M Company, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING RATE OF SURGERIES
    • 3.1.2. SURGE IN GERIATRIC POPULATION
    • 3.1.3. IMPLEMENTATION OF REGULATORY GUIDELINES FOR THE PREVENTION OF HOSPITAL ACQUIRED INFECTION
    • 3.1.4. INCREASED INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. LACK OF AWARENESS WITH REGARDS TO THE HOSPITAL-ACQUIRED INFECTIONS
    • 3.2.2. SURGING MEDICAL WASTE DUE TO THE USE OF MEDICAL DISPOSABLE ITEMS

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON SURGICAL SITE INFECTION CONTROL MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PROCEDURE

  • 5.1. LAPAROSCOPY
  • 5.2. ORTHOPEDIC SURGERY
  • 5.3. CARDIOVASCULAR
  • 5.4. OBSTETRICS AND GYNECOLOGY
  • 5.5. WOUND CLOSURE
  • 5.6. PLASTIC & RECONSTRUCTIVE SURGERY
  • 5.7. THORACIC SURGERY
  • 5.8. MICROVASCULAR
  • 5.9. UROLOGY
  • 5.10. NEUROSURGERY
  • 5.11. OTHER PROCEDURES

6. MARKET BY TYPE OF INFECTION

  • 6.1. SUPERFICIAL INCISIONAL SSI
  • 6.2. DEEP INCISIONAL SSI
  • 6.3. ORGAN OR SPACE SSI

7. MARKET BY END-USER

  • 7.1. HOSPITALS
  • 7.2. AMBULATORY SURGICAL CENTERS

8. MARKET BY PRODUCT

  • 8.1. DISINFECTANTS
  • 8.2. MANUAL REPROCESSORS SOLUTION
  • 8.3. SURGICAL DRAPES
  • 8.4. SURGICAL GLOVES
  • 8.5. SKIN PREPARATION SOLUTION
  • 8.6. SURGICAL IRRIGATION
  • 8.7. SURGICAL SCRUBS
  • 8.8. HAIR CLIPPERS
  • 8.9. MEDICAL NONWOVENS
  • 8.10. OTHER PRODUCTS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. ASIA PACIFIC
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. CHINA
      • 9.1.5.2. JAPAN
      • 9.1.5.3. AUSTRALIA & NEW ZEALAND
      • 9.1.5.4. INDIA
      • 9.1.5.5. SOUTH KOREA
      • 9.1.5.6. THAILAND
      • 9.1.5.7. INDONESIA
      • 9.1.5.8. VIETNAM
      • 9.1.5.9. REST OF ASIA PACIFIC

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGER & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 10.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 10.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 10.2. COMPANY PROFILES
    • 10.2.1. 3M COMPANY
    • 10.2.2. AMERICAN POLYFILM
    • 10.2.3. ANSELL LTD
    • 10.2.4. BECTON, DICKINSON AND COMPANY (BD)
    • 10.2.5. BELIMED AG
    • 10.2.6. BIOMERIEUX SA
    • 10.2.7. GAMA HEALTHCARE
    • 10.2.8. GETINGE AB
    • 10.2.9. JOHNSON & JOHNSON
    • 10.2.10. KIMBERLY-CLARK
    • 10.2.11. LAC-MAC
    • 10.2.12. PACON MANUFACTURING CORPORATION
    • 10.2.13. SOTERA HEALTH LLC
    • 10.2.14. STERIS CORPORATION
    • 10.2.15. STRYKER CORPORATION

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SURGICAL SITE INFECTION CONTROL
  • TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER, 2019 AND 2050
  • TABLE 3: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 4: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 5: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 6: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 7: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 8: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 9: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 10: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 11: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 12: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 13: LEADING PLAYERS OPERATING IN ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET

LIST OF FIGURES

  • FIGURE 1: COMMON TYPES OF HAIS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, IN 2020
  • FIGURE 7: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
  • FIGURE 8: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
  • FIGURE 9: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
  • FIGURE 10: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $ MILLION)
  • FIGURE 11: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
  • FIGURE 12: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028 (IN $ MILLION)
  • FIGURE 13: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
  • FIGURE 14: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
  • FIGURE 15: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
  • FIGURE 16: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
  • FIGURE 17: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
  • FIGURE 18: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, IN 2020
  • FIGURE 19: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)
  • FIGURE 20: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
  • FIGURE 21: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
  • FIGURE 22: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, IN 2020
  • FIGURE 23: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
  • FIGURE 25: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, IN 2020
  • FIGURE 26: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
  • FIGURE 27: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)
  • FIGURE 28: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
  • FIGURE 29: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
  • FIGURE 30: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)
  • FIGURE 31: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
  • FIGURE 32: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
  • FIGURE 33: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
  • FIGURE 34: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
  • FIGURE 35: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
  • FIGURE 36: ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 37: CHINA SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: JAPAN SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: AUSTRALIA & NEW ZEALAND SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: INDIA SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: THAILAND SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: INDONESIA SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: VIETNAM SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: REST OF ASIA PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)